Clicky

Exicure, Inc.(XCUR) News

Date Title
Apr 14 Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
Apr 11 Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)
Aug 26 Exicure, Inc. Announces 1-for-5 Reverse Stock Split
Aug 19 Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting
Jun 6 Exicure, Inc. Reports Full Year 2023 Financial Results
May 16 Exicure, Inc. Reports Third Quarter 2023 Financial Results
Nov 28 Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
Aug 11 Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update